The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 6,327,302 | 475,737 | SH | SOLE | 475,737 | 0 | 0 | ||
| ABIVAX SA | SPONSORED ADS | 00370M103 | 3,518,064 | 26,400 | SH | SOLE | 26,400 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 180,756,457 | 7,144,524 | SH | SOLE | 7,144,524 | 0 | 0 | ||
| AKTIS ONCOLOGY INC | COM | 01021M104 | 51,311,546 | 1,592,043 | SH | SOLE | 1,592,043 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 87,623,093 | 1,672,356 | SH | SOLE | 1,672,356 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 6,760,000 | 3,250,000 | SH | SOLE | 3,250,000 | 0 | 0 | ||
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 30,894,119 | 7,426,471 | SH | SOLE | 7,426,471 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 658,202,715 | 709,446 | SH | SOLE | 709,446 | 0 | 0 | ||
| ATAIBECKLEY INC | COM SHS | 04650F101 | 10,540,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 3,234,000 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 46,724,695 | 1,011,576 | SH | SOLE | 1,011,576 | 0 | 0 | ||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 19,575,922 | 570,394 | SH | SOLE | 570,394 | 0 | 0 | ||
| BELITE BIO INC | SPONSORED ADS | 07782B104 | 110,150,398 | 715,332 | SH | SOLE | 715,332 | 0 | 0 | ||
| BETA BIONICS INC | COM | 08659B102 | 23,505,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| CANDEL THERAPEUTICS INC | COM | 137404109 | 66,146,785 | 6,422,018 | SH | SOLE | 6,422,018 | 0 | 0 | ||
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 6,020,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CASTLE BIOSCIENCES INC | COM | 14843C105 | 66,263,290 | 2,778,335 | SH | SOLE | 2,778,335 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 345,758,952 | 3,304,903 | SH | SOLE | 3,304,903 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 21,304,347 | 8,695,652 | SH | SOLE | 8,695,652 | 0 | 0 | ||
| CG ONCOLOGY INC | COM | 156944100 | 604,961,620 | 8,514,590 | SH | SOLE | 8,514,590 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 89,359,113 | 2,309,021 | SH | SOLE | 2,309,021 | 0 | 0 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 151,418,782 | 10,700,974 | SH | SOLE | 10,700,974 | 0 | 0 | ||
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | 6,711,408 | 372,856 | SH | SOLE | 372,856 | 0 | 0 | ||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 43,054,759 | 2,364,347 | SH | SOLE | 2,364,347 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 243,814,036 | 2,862,003 | SH | SOLE | 2,862,003 | 0 | 0 | ||
| DANAHER CORP DEL | COM | 235851102 | 43,810,400 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 18,816,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 24,181,181 | 248,063 | SH | SOLE | 248,063 | 0 | 0 | ||
| DISC MEDICINE INC | COM | 254604101 | 2,194,200 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| ERASCA INC | COM | 29479A108 | 328,784,533 | 17,946,754 | SH | SOLE | 17,946,754 | 0 | 0 | ||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 227,885,188 | 2,655,695 | SH | SOLE | 2,655,695 | 0 | 0 | ||
| EVOMMUNE INC | COM SHS | 30054Y107 | 19,964,703 | 1,502,235 | SH | SOLE | 1,502,235 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 906,750 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 159,500,947 | 5,933,815 | SH | SOLE | 5,933,815 | 0 | 0 | ||
| GUARDANT HEALTH INC | COM | 40131M109 | 222,199,381 | 1,481,033 | SH | SOLE | 1,481,033 | 0 | 0 | ||
| HEARTFLOW INC | COM | 42238D107 | 8,655,300 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
| HINGE HEALTH INC | CL A | 433313103 | 41,500,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 13,803,690 | 370,370 | SH | SOLE | 370,370 | 0 | 0 | ||
| IMAGENEBIO INC | COM | 45175G207 | 1,973,226 | 334,445 | SH | SOLE | 334,445 | 0 | 0 | ||
| IMMATICS N.V | SHS | N44445109 | 131,144,763 | 12,946,176 | SH | SOLE | 12,946,176 | 0 | 0 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 154,616,087 | 4,869,798 | SH | SOLE | 4,869,798 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 122,442,522 | 3,177,849 | SH | SOLE | 3,177,849 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 516,347,866 | 4,842,880 | SH | SOLE | 4,842,880 | 0 | 0 | ||
| IRHYTHM HOLDINGS INC | COM | 450056106 | 259,623,957 | 2,182,631 | SH | SOLE | 2,182,631 | 0 | 0 | ||
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | 237,413,345 | 10,776,820 | SH | SOLE | 10,776,820 | 0 | 0 | ||
| KALARIS THERAPEUTICS INC | COM | 482929106 | 5,291,000 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| KODIAK SCIENCES INC | COM | 50015M109 | 57,969,909 | 1,487,934 | SH | SOLE | 1,487,934 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 27,520,800 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 7,826,297 | 2,565,999 | SH | SOLE | 2,565,999 | 0 | 0 | ||
| LUMEXA IMAGING HOLDINGS INC | COM | 550249106 | 7,332,000 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 1,070,510,235 | 1,993,687 | SH | SOLE | 1,993,687 | 0 | 0 | ||
| MAZE THERAPEUTICS INC | COM | 578784100 | 6,326,080 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
| MEDLINE INC | COM CL A | 58507V107 | 2,760,800 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 10,496,670 | 7,833,336 | SH | SOLE | 7,833,336 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 271,450,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 213,689,740 | 1,267,925 | SH | SOLE | 1,267,925 | 0 | 0 | ||
| NEUROGENE INC | COM | 64135M105 | 42,849,241 | 1,362,456 | SH | SOLE | 1,362,456 | 0 | 0 | ||
| OCUGEN INC | COM | 67577C105 | 10,199,999 | 6,666,666 | SH | SOLE | 6,666,666 | 0 | 0 | ||
| ORCHESTRA BIOMED HLDGS INC | COM | 68572M106 | 41,234,412 | 9,556,063 | SH | SOLE | 9,556,063 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 298,741,485 | 3,139,030 | SH | SOLE | 3,139,030 | 0 | 0 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | 8,078,400 | 742,500 | SH | SOLE | 742,500 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 620,398,832 | 5,061,175 | SH | SOLE | 5,061,175 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 631,875,072 | 7,746,415 | SH | SOLE | 7,746,415 | 0 | 0 | ||
| RADNET INC | COM | 750491102 | 298,911,900 | 4,846,958 | SH | SOLE | 4,846,958 | 0 | 0 | ||
| REPLIGEN CORP | COM | 759916109 | 169,272,512 | 1,240,637 | SH | SOLE | 1,240,637 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 82,046,202 | 7,411,581 | SH | SOLE | 7,411,581 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 60,492,180 | 17,687,772 | SH | SOLE | 17,687,772 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 1,190 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 36,666,661 | 5,952,380 | SH | SOLE | 5,952,380 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 38,890,331 | 3,892,926 | SH | SOLE | 3,892,926 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 377,492,205 | 4,251,996 | SH | SOLE | 4,251,996 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 184,001,738 | 5,623,525 | SH | SOLE | 5,623,525 | 0 | 0 | ||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 86,274,901 | 1,607,507 | SH | SOLE | 1,607,507 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 434,533,381 | 13,900,620 | SH | SOLE | 13,900,620 | 0 | 0 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 211,293,293 | 3,357,059 | SH | SOLE | 3,357,059 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 92,345,357 | 13,560,258 | SH | SOLE | 13,560,258 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 10,135,094 | 696,570 | SH | SOLE | 696,570 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 260,338,324 | 7,796,895 | SH | SOLE | 7,796,895 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 181,548,806 | 3,941,572 | SH | SOLE | 3,941,572 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 167,215,336 | 4,543,895 | SH | SOLE | 4,543,895 | 0 | 0 | ||
| VERASTEM INC | COM NEW | 92337C203 | 25,348,729 | 6,635,793 | SH | SOLE | 6,635,793 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 7,843,500 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 109,117,122 | 6,777,461 | SH | SOLE | 6,777,461 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 124,906,608 | 6,574,032 | SH | SOLE | 6,574,032 | 0 | 0 | ||